EUVIMEDEUVIMED entdecken
Crossref

Treatment effect estimation in seamless phase II/III trials with treatment selection: A nonparametric bootstrap approach

Parsa Jamshidian, Zhiwei Zhang

Contemporary Clinical Trials · 2026-11 · 170 · 108449

DOI: 10.1016/j.cct.2026.108449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2026-11. Verfasst von Parsa Jamshidian und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of California Los Angeles, United States. Hauptthemen laut MEDLINE: Clinical Trials, Phase III as Topic, Clinical Trials, Phase II as Topic, Research Design. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seamless phase II/III clinical trials offer an efficient way to select an experimental treatment and perform a confirmatory analysis within a single trial. Despite their operational advantages, such designs pose serious statistical challenges including control of the family-wise type I error rate and adjusting for selection-induced bias in treatment-effect estimation. We propose a nonparametric bootstrap method for estimating the phase III treatment effect that leverages data from both phases while avoiding reliance on potentially unrealistic parametric assumptions. The proposed estimator is simple and general, and explicitly adjusts for the bias induced by data-driven treatment selection in phase II. Its wide applicability is illustrated through examples involving different types of outcomes. The operating characteristics of the estimator are further evaluated through simulation studies, demonstrating substantially reduced bias compared with the naïve estimator that simply pools data from phases II and III.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase III as TopicClinical Trials, Phase II as TopicResearch DesignHumansStatistics, NonparametricModels, StatisticalComputer SimulationTreatment Outcome

Stichwörter der Autor:innen

Adaptive designBias correctionConditional inferenceDose selectionDrop-the-loser designSelection bias

Autor:innen und Institutionen

  • University of California Los Angeles, United States.
  • Gilead Sciences Inc, United States. Electronic address: Zhiwei.Zhang6@gilead.com.

Zitieren

APA

Jamshidian, P., & Zhang, Z. (2026). Treatment effect estimation in seamless phase II/III trials with treatment selection: A nonparametric bootstrap approach. Contemporary Clinical Trials, 170, 108449. https://doi.org/10.1016/j.cct.2026.108449

Vancouver

Jamshidian P, Zhang Z. Treatment effect estimation in seamless phase II/III trials with treatment selection: A nonparametric bootstrap approach. Contemporary Clinical Trials. 2026;170:108449. doi:10.1016/j.cct.2026.108449

BibTeX
@article{Jamshidian2026,
  author = {Jamshidian, Parsa and Zhang, Zhiwei},
  title = {Treatment effect estimation in seamless phase II/III trials with treatment selection: A nonparametric bootstrap approach},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {170},
  pages = {108449},
  doi = {10.1016/j.cct.2026.108449}
}
Kostenlos starten →